
|Videos|February 15, 2023
Case 1: Faricimab in a high-need neovascular nAMD patient
Advertisement
Dr. Khanani shares the case of a neovascular nAMD patient with high disease activity who achieved significant vision improvement and fluid resolution after switching to faricimab.
Sponsored by Roche
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Ophthalmic drug shortages more frequent, longer lasting than average
2
ONL Therapeutics randomizes first European patient in phase 2 GA trial of Xelafaslatide
3
Genetic Retinoblastoma Risk Stratified by Age Among Patients with Metachronous Bilateral Conversion
4

































